Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BISOPROLOL vs BOCOCIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BISOPROLOL vs BOCOCIZUMAB: Safety Overview

Metric BISOPROLOL BOCOCIZUMAB
Total FAERS Reports 27,755 122
Deaths Reported 2,541 1
Death Rate 9.2% 0.8%
Hospitalizations 15,394 114
Average Patient Age 69.3 yrs 61.8 yrs
% Female Patients 49.1% 27.1%
FDA Approval Date Apr 16, 2025 N/A
Manufacturer Unichem Pharmaceuticals (USA), Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A